Fatty Liver Disease Renamed as Global Cases Surge Beyond One Billion
A condition previously known as nonalcoholic fatty liver disease (NAFLD) has been renamed to metabolic dysfunction-associated steatotic liver disease, or MASLD. Affecting roughly one in three people worldwide, it is currently the most common chronic liver disease. Unlike liver damage caused by alcohol, MASLD occurs when excess fat accumulates in the liver due to underlying metabolic issues. Common risk factors include obesity, type 2 diabetes, and conditions like insulin resistance. Lifestyle habits, such as poor diet, lack of exercise, and metabolic syndrome, also significantly contribute to its development. With approximately one-third of the global population affected, MASLD remains a leading cause of chronic liver disease. Recognizing risk factors and seeking early medical advice can help prevent severe complications. Treatment and lifestyle changes may halt the disease's progression or even restore liver health.
